Knowledge, Attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
Knowledge,attitude &practice on Human Papilloma Virus Vaccination Among Healthcare Providers and General Population
1 other identifier
observational
323
0 countries
N/A
Brief Summary
- Cervical cancer is caused by persistent infection with certain strains of the human papillomavirus (HPV), which is a very common virus transmitted through sexual activity.
- HPV infections can lead to the development of precancerous lesions on the cervix, which if left untreated, can progress to invasive cervical cancer over time.
- Cervical cancer is the second most common cancer among women in Egypt, after breast cancer.
- According to the latest available data, the age-standardized incidence rate of cervical cancer in Egypt is approximately 6.3 per 100,000 women.
- However, the actual burden of cervical cancer in Egypt is likely underestimated, as many cases may go undetected or unreported, especially in rural and underserved areas. The main objectives of this KAP study are:
- To assess the level of knowledge about HPV and HPV vaccination among the target population.
- To investigate the attitudes and perceptions towards HPV vaccination.
- To identify the current practices and uptake of HPV vaccination.
- To explore the factors influencing the knowledge, attitudes, and practices related to HPV vaccination.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2024
CompletedFirst Posted
Study publicly available on registry
December 20, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedDecember 20, 2024
December 1, 2024
Same day
December 17, 2024
December 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Knowledge about HPV
Proportion of participants with adequate knowledge about HPV
baseline
Knowledge about HPV Vaccination
Proportion of participants with adequate knowledge about the HPV vaccine
baseline
Study Arms (1)
health care provider group
\- Healthcare providers at the Gynecologic Oncology Unit have direct interactions with patients and can significantly influence their knowledge, attitudes, and decision-making regarding HPV vaccination.
Eligibility Criteria
Physicians, nurses, and other healthcare workers employed in the Obstetrics and Gynecology, and Family Medicine departments at Assiut University Hospital.
You may qualify if:
- \. general population:
- Eligibility criteria:
- Age: 9-79 years old
- patients and their relatives
- Attending the Obstetrics and Gynecology, or Family Medicine clinics at Assiut University Hospital
- Recruitment strategy:
- Using a systematic random sampling method, every nth patient (based on the average patient load) will be approached and invited to participate in the study.
- The target sample size for patients is a minimum of 384 participants.
- \. Healthcare providers:
- Eligibility criteria:
- Physicians, nurses, and other healthcare workers employed in the Obstetrics and Gynecology, and Family Medicine departments at Assiut University Hospital.
You may not qualify if:
- Previous HPV Vaccination:
- Exclude participants who have already received the complete HPV vaccination series, as their knowledge, attitudes, and practices may differ from those who are unvaccinated.
- The study aims to understand the KAP of the unvaccinated population, which is the primary target group for intervention.
- Severe Cognitive or Mental Impairment:
- Exclude participants who have severe cognitive or mental impairments that may prevent them from understanding and responding to the questionnaire accurately.
- This could include individuals with advanced dementia, severe intellectual disabilities, or acute psychiatric conditions.
- Inability to Provide Informed Consent:
- Exclude participants who are unable to provide informed consent due to language barriers, literacy issues, or other factors that may compromise their ability to understand the study and its implications 4- Severe Illness or Hospitalization:
- Exclude participants who are currently hospitalized or experiencing severe illness, as their focus may be on their immediate health concerns rather than the KAP questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007 Aug-Sep;45(2-3):107-14. doi: 10.1016/j.ypmed.2007.05.013. Epub 2007 Jun 2.
PMID: 17628649BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident doctor at Assiut University hospital
Study Record Dates
First Submitted
December 17, 2024
First Posted
December 20, 2024
Study Start
January 1, 2025
Primary Completion
January 1, 2025
Study Completion
March 1, 2026
Last Updated
December 20, 2024
Record last verified: 2024-12